Literature DB >> 12423364

Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.

Orlando Crescenzi1, Simona Tomaselli, Remo Guerrini, Severo Salvadori, Anna M D'Ursi, Piero Andrea Temussi, Delia Picone.   

Abstract

The major components of neuritic plaques found in Alzheimer disease (AD) are peptides known as amyloid beta-peptides (Abeta), which derive from the proteolitic cleavage of the amyloid precursor proteins. In vitro Abeta may undergo a conformational transition from a soluble form to aggregated, fibrillary beta-sheet structures, which seem to be neurotoxic. Alternatively, it has been suggested that an alpha-helical form can be involved in a process of membrane poration, which would then trigger cellular death. Conformational studies on these peptides in aqueous solution are complicated by their tendency to aggregate, and only recently NMR structures of Abeta-(1-40) and Abeta-(1-42) have been determined in aqueous trifluoroethanol or in SDS micelles. All these studies hint to the presence of two helical regions, connected through a flexible kink, but it proved difficult to determine the length and position of the helical stretches with accuracy and, most of all, to ascertain whether the kink region has a preferred conformation. In the search for a medium which could allow a more accurate structure determination, we performed an exhaustive solvent scan that showed a high propensity of Abeta-(1-42) to adopt helical conformations in aqueous solutions of fluorinated alcohols. The 3D NMR structure of Abeta-(1-42) shows two helical regions encompassing residues 8-25 and 28-38, connected by a regular type I beta-turn. The surprising similarity of this structure, as well as the sequence of the C-terminal moiety, with those of the fusion domain of influenza hemagglutinin suggests a direct mechanism of neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423364     DOI: 10.1046/j.1432-1033.2002.03271.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  151 in total

1.  A study of the α-helical intermediate preceding the aggregation of the amino-terminal fragment of the β amyloid peptide (Aβ(1-28)).

Authors:  Ana V Rojas; Adam Liwo; Harold A Scheraga
Journal:  J Phys Chem B       Date:  2011-10-18       Impact factor: 2.991

Review 2.  From Alzheimer to Huntington: why is a structural understanding so difficult?

Authors:  Piero Andrea Temussi; Laura Masino; Annalisa Pastore
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

3.  Molecular dynamics simulation of amyloid beta dimer formation.

Authors:  B Urbanc; L Cruz; F Ding; D Sammond; S Khare; S V Buldyrev; H E Stanley; N V Dokholyan
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

4.  Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.

Authors:  Yu-Shan Lin; Gregory R Bowman; Kyle A Beauchamp; Vijay S Pande
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

5.  Distinguishing amyloid fibril structures in Alzheimer's disease (AD) by two-dimensional ultraviolet (2DUV) spectroscopy.

Authors:  A R Lam; J Jiang; S Mukamel
Journal:  Biochemistry       Date:  2011-10-20       Impact factor: 3.162

6.  Adsorption mechanism and collapse propensities of the full-length, monomeric Aβ(1-42) on the surface of a single-walled carbon nanotube: a molecular dynamics simulation study.

Authors:  Asis K Jana; Neelanjana Sengupta
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

7.  Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.

Authors:  Robin Altman; Sonny Ly; Silvia Hilt; Jitka Petrlova; Izumi Maezawa; Tamás Kálai; Kálmán Hideg; Lee-Way Jin; Ted A Laurence; John C Voss
Journal:  Biochim Biophys Acta       Date:  2015-09-14

8.  Computational and experimental studies on β-sheet breakers targeting Aβ1-40 fibrils.

Authors:  Velia Minicozzi; Roberta Chiaraluce; Valerio Consalvi; Cesare Giordano; Claudia Narcisi; Pasqualina Punzi; Giancarlo C Rossi; Silvia Morante
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

9.  Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast.

Authors:  Afsaneh Porzoor; Joanne M Caine; Ian G Macreadie
Journal:  Prion       Date:  2014       Impact factor: 3.931

Review 10.  Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

Authors:  Hyunbum Jang; Laura Connelly; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Bruce L Kagan; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2013-02-28       Impact factor: 3.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.